Science
Bharat Biotech's Intranasal Covid-19 Vaccine-iNCOVACC. (Pic via Twitter).
The first Made-in-India intranasal Covid vaccine, Bharat Biotech’s ‘iNCOVACC’, was launched today (26 January), by Union Health Minister Mansukh Mandaviya and Science and Technology Minister Jitendra Singh.
Bharat Biotech’s intranasal vaccine, BBV154 or iNCOVACC is the world’s first intranasal vaccine to be approved as a booster dose for Covid-19.
The nasal vaccine is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion stabilized spike protein.
With the vaccine being delivered through a nasal spray, it will do away with the need for needles and syringes, currently required for all the Covid-19 vaccines available.
Since the nasal vaccine gives local immunity (in the nose where the virus first enters), it is more likely to be effective at preventing transmission, than the current generation of vaccines we have.
Bharat Biotech had in December 2022, got the approval for the primary 2-dose schedule, and as a heterologous booster dose. Before that, the Central Drugs Standard Control Organisation (CDSCO) had approved the restricted use of the intranasal vaccine in emergency situations in the age group of 18 years and above.
According to a statement issued by Bharat Biotech earlier, 'iNCOVACC' is priced at Rs 800 for private markets, and at Rs 325 for supplies to the government of India and state governments.
This vaccine candidate was evaluated in phase I, II and III clinical trials with successful results, the Hyderabad-based vaccine maker had said. Phase III trials of the vaccine were conducted on 3,100 participants at 14 trial sites, across India, to evaluate immunogenicity and safety.
Support Swarajya's 50 Ground Reports Project & Sponsor A Story
Every general election Swarajya does a 50 ground reports project.
Aimed only at serious readers and those who appreciate the nuances of political undercurrents, the project provides a sense of India's electoral landscape. As you know, these reports are produced after considerable investment of travel, time and effort on the ground.
This time too we've kicked off the project in style and have covered over 30 constituencies already. If you're someone who appreciates such work and have enjoyed our coverage please consider sponsoring a ground report for just Rs 2999 to Rs 19,999 - it goes a long way in helping us produce more quality reportage.
You can also back this project by becoming a subscriber for as little as Rs 999 - so do click on this links and choose a plan that suits you and back us.
Click below to contribute.
Latest